Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

NCT06208657 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Childhood Cancer
Childhood Solid Tumor
Childhood Brain Tumor
Recurrent Cancer
Refractory Cancer

Interventions

DRUG: Paxalisib
DRUG: Opdualag
DRUG: Irinotecan (drug)
DRUG: Temozolomide (TMZ)

Sponsor

Australian & New Zealand Children's Haematology/Oncology Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]